Xerostomia one of the Sjögren’s Syndrome Symptoms PDF Print E-mail
Wednesday, 09 June 2010 09:25
“The American Health Institute spent $8 million for a research diagnosis of Sjögren syndrome in several countries as an important disease with high impact on society,” he told The Capital Dr. Ricardo Bazet, ophthalmologist, director of Rosario Self-Help Association for Sjögren syndrome.

One of its main characteristics is the difficulty of arriving at a diagnosis by the multiplicity of symptoms that occurs. This makes the number of fuzzy diagnoses that prevent proper treatment of the disease. “Patients with borderline diagnoses are offered the opportunity to be studies in the German Hospital in Buenos Aires, but not treatment, which should continue in the city of origin,” says Bazet. “The symptoms are not all together,” says the doctor. May occur in different organs by which each specialist is usually just look what it is and not the whole problem. “

Patients who join the study was carried out laboratory tests with blood collection, study eye, Schirmer test, BUT and ocular staining test (fluorescein and lissamine), total and parotid saliva, rheumatologic clinical examination and biopsy of the salivary gland lower. The results of the studies will travel to the U.S. where will supervise each case and classify the data. Finally, the patient returns to information processing will continue with regular doctor.

“The doctors evaluate patients who travel to Buenos Aires for the test. We think it will be two per month, “says the director of the association Rosario, who acknowledges the existence of many patients with misdiagnoses. “The fact that each case is evaluated by the best band in the world Sjögren study determined to be classified the extent of disease (mild, moderate or severe) and that treatment is appropriate to the disease,” adds Bazet.

Treatment should be supervised by a rheumatologist who Bazet as recommended, “must work near an ophthalmologist, pathologist, biochemist and a dermatologist and gynecologist. It seeks to relieve symptoms for a better quality of life, ranging from how to eat, what glasses to use, how to bathe and hydrate the skin, among other guidelines. “

Sjogren’s is an autoimmune disease that causes widespread disruption of the functioning of all the glands of external secretion. The sensation of dry mouth with dry eye are one of the most common. This occurs by decreasing the amount of saliva (hiposalia) or total lack thereof (xerostomia). In most cases occur in this way and a few percent is associated with other autoimmune diseases such as lupus, Scleroderma and psoriasis.

Source: University Five

 
More articles :

» Positive Phase II Results for AIMSPRO In Scleroderma Announced

announced yesterday, positive results from its Double-Blind Placebo-Controlled Phase II Clinical Study evaluating the safety and tolerability of AIMSPRO given as a monotherapy to patients with Late Stage Established Diffuse Cutaneous Systemic...

» Rituximab Shows Promise in Scleroderma

Rituximab (Rituxan) improved lung function in patients with , a small proof-of-principle study found.At one year, patients randomized to receive rituximab had a median 10.25% increase in forced vital capacity (FVC) compared with baseline, while...

» What Is Autoimmune Hepatitis?

Autoimmune hepatitis is an of the caused by an autoimmune disorder. An autoimmune disorder is one in which a person's immune system attacks his or her own body for unknown reasons. The degree of liver inflammation can range from mild to deadly.The...

» Study Indicates Scleroderma Mortality Rates Being Underestimated

patients have a significantly reduced life expectancy that is most likely being underestimated, delegates have heard. Most studies on scleroderma survival are based on prevalent cohorts, where no limit is placed on disease duration at the time of...

» Small Intestinal Bacterial Overgrowth A Problem For Scleroderma Patients

More than a third of patients with systemic sclerosis and intestinal symptoms have an increase in gastrointestinal tract bacteria, an alteration in the type of gut microbes present, or both, based on data from a French study presented at the annual...

» arGentis Issued Key Patent Related to Treating Fibrosing Diseases by Induction of Immune Tolerance

arGentis Pharmaceuticals, LLC today announced the issuance of United States patent 7,718,765, entitled “Methods for Treating Fibrosing Diseases by Induction of Immune Tolerance." The issued patent, based on the seminal research of Arnold E....